B of A Securities Maintains Buy on Syndax Pharmaceuticals, Raises Price Target to $31
B of A Securities Maintains Buy on Syndax Pharmaceuticals, Raises Price Target to $31
B of A Securities維持對syndax pharmaceuticals的買入評級，將目標價提高至31美元。
B of A Securities analyst Jason Zemansky maintains Syndax Pharmaceuticals (NASDAQ:SNDX) with a Buy and raises the price target from $30 to $31.
B of A Securities的分析師Jason Zemansky認爲Syndax Pharmaceuticals（納斯達克股票代碼：SNDX）的評級仍爲買入，並將目標股價從30美元上調至31美元。
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。